切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2013, Vol. 09 ›› Issue (06) : 801 -804. doi: 10.3877/cma.j.issn.1673-5250.2013.06.019

所属专题: 文献

论著

匹多莫德联合布地奈德气雾剂治疗儿童支气管哮喘的疗效及安全性研究
谢莉1, 刘蓉1, 李艳1,*,*(), 佘静1   
  1. 1. 621000 绵阳市中心医院儿科
  • 收稿日期:2013-06-12 修回日期:2013-11-05 出版日期:2013-12-01
  • 通信作者: 李艳

Efficacy and Safety of Pidotimod Combined With Budesonide Aerosol in the Treatment of Bronchial Asthma in Children

Li XIE1, Rong LIU1, Yan LI1(), Jing YU1   

  1. 1. Department of Pediatrics , Central Hospital of Mianyang, Mianyang 621000, Sichuan Province, China
  • Received:2013-06-12 Revised:2013-11-05 Published:2013-12-01
  • Corresponding author: Yan LI
  • About author:
    (Corresponding author : LI Yan , Email : )
引用本文:

谢莉, 刘蓉, 李艳, 佘静. 匹多莫德联合布地奈德气雾剂治疗儿童支气管哮喘的疗效及安全性研究[J]. 中华妇幼临床医学杂志(电子版), 2013, 09(06): 801-804.

Li XIE, Rong LIU, Yan LI, Jing YU. Efficacy and Safety of Pidotimod Combined With Budesonide Aerosol in the Treatment of Bronchial Asthma in Children[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2013, 09(06): 801-804.

目的

探讨匹多莫德联合布地奈德气雾剂治疗儿童支气管哮喘的疗效及安全性。

方法

选取2011年6月至2012年9月于绵阳市中心医院儿科门诊治疗的200例支气管哮喘患儿为研究对象,根据治疗方法不同,将其分为观察组(n= 100,匹多莫德+布地奈德气雾剂)和对照组(n= 100,仅用布地奈德气雾剂)。两组患儿的性别、平均年龄、病程及病情严重程度分级等基础资料比较,差异无统计学意义(P> 0.05)(本研究遵循的程序符合绵阳市中心医院人体试验委员会制定的伦理学标准,得到该委员会批准,分组征得受试患儿监护人的知情同意,并与之签署临床研究知情同意书)。比较两组患儿的疗效、哮喘发作次数、发作持续时间等。

结果

观察组的总有效率明显高于对照组(95.00% vs. 74.00%,P<0.01)。观察组的哮喘发作持续时间[(4.00±1. 32) d vs. (6. 78±1.58) d,P<0. 05]以及发作程度(P<0. 01)均明显短于对照组。

结论

匹多莫德联合布地奈德气雾剂治疗儿童支气管哮喘疗效更佳。

Objective

To investigate the efficacy and safety of pidotimod combined with budesonide aerosol in the treatment of bronchial asthma in children.

Methods

Selected 200 cases children with asthma treated in hospital outpatient from June 2011 to September 2012 as research subjects. They were randomly divided into observation group (n = 100,budesonide aerosol + pidotimod) and control group (n = 100, budesonide aerosol) according to the different therapeutic methods. Comparison of the two groups of gender, average age,duration and severity grading and other basic information on aspects of children, the differences were not statistically significant (P>0. 05). In this study, the procedure followed in line with ethical standards established by Institutional Review Board of the Central Hospital of Mianyang, approved by the Commission, grouping the consent of the guardian of the children tested, and with the signing of informed consent in clinical research. The following information were compared between two groups,the number of asthma attacks,attack duration and extent of attack.

Results

The efficient of observation group was significantly higher than that in control group(95. 00% vs. 74. 00%,P<0. 01). The number of asthma attacks, attack duration [(4. 00±1. 32) d vs. (6. 78 ± 1. 58) d,P<0. 05] and extent of attack(P<0. 01) were significantly shorter than those of control group.

Conclusions

Pidotimod combined with budesonide aerosol in the treatment of bronchial asthma in children is better than budesonide only.

表1 支气管哮喘患儿病情严重程度的分级
Table 1 Classification of asthma severity
表2 两组患儿一般资料比较(±s)
Table 2 Comparison of general information between two groups ( ± s)
表3 哮喘急性发作期病情严重程度的分级
Table 3 Acute episodes of asthma severity classification
表4 两组疗效比较[n(%)]
Table 4 Comparison of efficacy between two groups[n(%)]
表5 两组患儿哮喘发作程度及持续时间的比较(±s)
Table 5 Comparison of degree and duration of acute attack of asthma between two groups(±s)
表6 两组患儿不良反应比较[n(%)]
Table 6 Comparison of adverse reactions between two groups[n(%)]
1
Yim RP, Koumbourlis AC. Steroid-resistant asthma [J]. Paediatr Respir Rev, 2012,13(3): 172-176.
2
Gao L, Kong SQ. Research progress of asthma treating by glucocorticosteroid [J]. Chin J Pediatr, 1996,34(6) : 423-425.
3
Hu K. Glueocortieoid reeeptor and bronchial asthma [J]. Int J Respir, 1994,14(2): 61.
4
Buc M, Dzurilla M, Vrlik M,et al. Immunopathogenesis of bronchial asthma [J]. Arch Immunol Ther Exp (Warsz),2009,57 (5): 331-344.
5
Fleming DM, Elliot AJ. The management of acute bronchitis in children [J]. Expert Opin Pharmacother,2007,8(4) : 415-426.
6
Zhang SQ, Yue Y. Observation of pidotimod in the treatment of bronchial asthma in children [J]. Shandong Med J,2010,50(8): 74-75.
7
Huang RW, Yang RY, Yang HY, et al. The effect of pidotimod in the prevention and treatment of pediatric asthma [J]. J Pediatr Pharm, 2005, 11(3): 1672.
8
Wang ZY. Observation of pidotimod in the treatment of bronchial asthma in children [J]. Chin J Med Guide, 2010,12(5) : 110.
9
Tian XP, Zeng XF. A new synthetic immunomodulator pidotimod [J]. Chin J New Drug, 2005, 14(1): 111-114.
10
Chinese Medical Association of respiratory disease branch Asthma Study Group. Guideline for the diagnosis and optimal management of asthma in children [J]. Chin J Pediatr, 2008,46(10) : 745-753.
11
Liu XR, Ji MH. Related factor analysis recurrent lower respiratiory tract infection in children [J]. Med J Qilu,2003,17 (4): 11-12.
12
Li XZ, Zhang J, He ML, et al. Clinical observation of pidotimod in the treatment of children with recurrent respiratory tract infection [J]. Mod Prevent Med, 2008,35(19) : 3850-3851.
13
Rao XM, Mai LJ, Li LH. The clinical effective of pidotimod in treatment of children recurrent respiratory infections [J]. Med Recapitul, 2011,17(14): 2229-2230.
14
Ji P, Wang QC. The effect of inhaled low-dose hormone and β-rececptor agonist on asthma [J]. Acta Med Sinica,2011,24(6): 55-56.
15
Li Yan, Liu R, Yu J. Efficacy observation of budesonid with salbutamol in the treatment of acute lightly childhood astnma [J]. Sichuan Med J, 2011,32(6): 863-865.
16
Jiang CY. Clinical observation of pidotimod adjuvant therapy in infants with recurrent respiratory tract infections : 180 cases report [J]. China Foreign Med Treat, 2012,32(2): 11-12.
17
Zhai FX, Liu X. The effect of Pidotimod in the prevention and treatment of pediatric bronchial asthma [J]. Chin J Biochem Pharm, 2011,32(2): 151-152.
18
徐英.匹多莫德治疗小儿反复呼吸道感染80例疗效观察[J].现代医药卫生.2012(20).
19
Wang HY. Clinical application of pidotimod [J]. Mod Med Health, 2011,27(22): 3435-3436.
20
Zhao Y, Lyu FL. Application and experimental research progress of pidotimod in infectious diseases [J]. J Trop Med, 2012,12(8): 55-58.
[1] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1068-1073.
[2] 张宝富, 俞劲, 叶菁菁, 俞建根, 马晓辉, 刘喜旺. 先天性原发隔异位型肺静脉异位引流的超声心动图诊断[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1074-1080.
[3] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[4] 刘婷婷, 林妍冰, 汪珊, 陈幕荣, 唐子鉴, 代东伶, 夏焙. 超声衰减参数成像评价儿童代谢相关脂肪性肝病的价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 787-794.
[5] 周钰菡, 肖欢, 唐毅, 杨春江, 周娟, 朱丽容, 徐娟, 牟芳婷. 超声对儿童髋关节暂时性滑膜炎的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 795-800.
[6] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[7] 王宏宇. 固定与活动平台假体在全膝关节置换术中的应用价值[J]. 中华关节外科杂志(电子版), 2023, 17(06): 871-876.
[8] 米洁, 陈晨, 李佳玲, 裴海娜, 张恒博, 李飞, 李东杰. 儿童头面部外伤特点分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 511-515.
[9] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[10] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[11] 王蕾, 王少华, 牛海珍, 尹腾飞. 儿童腹股沟疝围手术期风险预警干预[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 768-772.
[12] 李芳, 许瑞, 李洋洋, 石秀全. 循证医学理念在儿童腹股沟疝患者中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 782-786.
[13] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[14] 刘笑笑, 张小杉, 刘群, 马岚, 段莎莎, 施依璐, 张敏洁, 王雅晳. 中国学龄前儿童先天性心脏病流行病学研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1021-1024.
[15] 李静, 张玲玲, 邢伟. 兴趣诱导理念用于小儿手术麻醉诱导前的价值及其对家属满意度的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 812-817.
阅读次数
全文


摘要